Global Dog Prescription Drugs Market Outlook 2021

Publisher Name :
Date: 19-Nov-2020
No. of pages: 91
Inquire Before Buying

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Dog Prescription Drugs market is segmented into

- Oral Type

- Smear Type

- Injection Type

- Spray Type

Segment by Application

- Hospital

- Clinic

- Others

Global Dog Prescription Drugs Market: Regional Analysis

The Dog Prescription Drugs market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Dog Prescription Drugs market report are:

- North America

- U.S.

- Canada

- Europe

- Germany

- France

- U.K.

- Italy

- Russia

- Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

- Latin America

- Mexico

- Brazil

- Argentina

- Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Dog Prescription Drugs Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Dog Prescription Drugs market include:

- Elanco Animal Health

- Ceva Sante Animale

- MSD Animal Health

- Zoetis

- Virbac

- Dechra

- Vetoquinol

- Animalcare Group

- Ourofino Saude Animal

- Boehringer Ingelheim

Global Dog Prescription Drugs Market Outlook 2021

Table of Contents
1 Dog Prescription Drugs Market Overview
1.1 Product Overview and Scope of Dog Prescription Drugs
1.2 Dog Prescription Drugs Segment by Type
1.2.1 Global Dog Prescription Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Oral Type
1.2.3 Smear Type
1.2.4 Injection Type
1.2.5 Spray Type
1.3 Dog Prescription Drugs Segment by Application
1.3.1 Dog Prescription Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Dog Prescription Drugs Market Size Estimates and Forecasts
1.4.1 Global Dog Prescription Drugs Revenue 2015-2026
1.4.2 Global Dog Prescription Drugs Sales 2015-2026
1.4.3 Dog Prescription Drugs Market Size by Region: 2020 Versus 2026
1.5 Dog Prescription Drugs Industry
1.6 Dog Prescription Drugs Market Trends
2 Global Dog Prescription Drugs Market Competition by Manufacturers
2.1 Global Dog Prescription Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Dog Prescription Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Dog Prescription Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Dog Prescription Drugs Manufacturing Sites, Area Served, Product Type
2.5 Dog Prescription Drugs Market Competitive Situation and Trends
2.5.1 Dog Prescription Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Dog Prescription Drugs Players (Opinion Leaders)
3 Dog Prescription Drugs Retrospective Market Scenario by Region
3.1 Global Dog Prescription Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Dog Prescription Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Dog Prescription Drugs Market Facts & Figures by Country
3.3.1 North America Dog Prescription Drugs Sales by Country
3.3.2 North America Dog Prescription Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dog Prescription Drugs Market Facts & Figures by Country
3.4.1 Europe Dog Prescription Drugs Sales by Country
3.4.2 Europe Dog Prescription Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dog Prescription Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Dog Prescription Drugs Sales by Region
3.5.2 Asia Pacific Dog Prescription Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Dog Prescription Drugs Market Facts & Figures by Country
3.6.1 Latin America Dog Prescription Drugs Sales by Country
3.6.2 Latin America Dog Prescription Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Dog Prescription Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Dog Prescription Drugs Sales by Country
3.7.2 Middle East and Africa Dog Prescription Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Dog Prescription Drugs Historic Market Analysis by Type
4.1 Global Dog Prescription Drugs Sales Market Share by Type (2015-2020)
4.2 Global Dog Prescription Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Dog Prescription Drugs Price Market Share by Type (2015-2020)
4.4 Global Dog Prescription Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Dog Prescription Drugs Historic Market Analysis by Application
5.1 Global Dog Prescription Drugs Sales Market Share by Application (2015-2020)
5.2 Global Dog Prescription Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Dog Prescription Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Dog Prescription Drugs Business
6.1 Elanco Animal Health
6.1.1 Corporation Information
6.1.2 Elanco Animal Health Description, Business Overview and Total Revenue
6.1.3 Elanco Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Elanco Animal Health Products Offered
6.1.5 Elanco Animal Health Recent Development
6.2 Ceva Sante Animale
6.2.1 Ceva Sante Animale Corporation Information
6.2.2 Ceva Sante Animale Description, Business Overview and Total Revenue
6.2.3 Ceva Sante Animale Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Ceva Sante Animale Products Offered
6.2.5 Ceva Sante Animale Recent Development
6.3 MSD Animal Health
6.3.1 MSD Animal Health Corporation Information
6.3.2 MSD Animal Health Description, Business Overview and Total Revenue
6.3.3 MSD Animal Health Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 MSD Animal Health Products Offered
6.3.5 MSD Animal Health Recent Development
6.4 Zoetis
6.4.1 Zoetis Corporation Information
6.4.2 Zoetis Description, Business Overview and Total Revenue
6.4.3 Zoetis Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Zoetis Products Offered
6.4.5 Zoetis Recent Development
6.5 Virbac
6.5.1 Virbac Corporation Information
6.5.2 Virbac Description, Business Overview and Total Revenue
6.5.3 Virbac Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Virbac Products Offered
6.5.5 Virbac Recent Development
6.6 Dechra
6.6.1 Dechra Corporation Information
6.6.2 Dechra Description, Business Overview and Total Revenue
6.6.3 Dechra Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Dechra Products Offered
6.6.5 Dechra Recent Development
6.7 Vetoquinol
6.6.1 Vetoquinol Corporation Information
6.6.2 Vetoquinol Description, Business Overview and Total Revenue
6.6.3 Vetoquinol Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Vetoquinol Products Offered
6.7.5 Vetoquinol Recent Development
6.8 Animalcare Group
6.8.1 Animalcare Group Corporation Information
6.8.2 Animalcare Group Description, Business Overview and Total Revenue
6.8.3 Animalcare Group Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Animalcare Group Products Offered
6.8.5 Animalcare Group Recent Development
6.9 Ourofino Saude Animal
6.9.1 Ourofino Saude Animal Corporation Information
6.9.2 Ourofino Saude Animal Description, Business Overview and Total Revenue
6.9.3 Ourofino Saude Animal Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 Ourofino Saude Animal Products Offered
6.9.5 Ourofino Saude Animal Recent Development
6.10 Boehringer Ingelheim
6.10.1 Boehringer Ingelheim Corporation Information
6.10.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
6.10.3 Boehringer Ingelheim Dog Prescription Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Boehringer Ingelheim Products Offered
6.10.5 Boehringer Ingelheim Recent Development
7 Dog Prescription Drugs Manufacturing Cost Analysis
7.1 Dog Prescription Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dog Prescription Drugs
7.4 Dog Prescription Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Dog Prescription Drugs Distributors List
8.3 Dog Prescription Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Dog Prescription Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dog Prescription Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Dog Prescription Drugs by Type (2021-2026)
10.2 Dog Prescription Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dog Prescription Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Dog Prescription Drugs by Application (2021-2026)
10.3 Dog Prescription Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dog Prescription Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Dog Prescription Drugs by Region (2021-2026)
10.4 North America Dog Prescription Drugs Estimates and Projections (2021-2026)
10.5 Europe Dog Prescription Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Dog Prescription Drugs Estimates and Projections (2021-2026)
10.7 Latin America Dog Prescription Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Dog Prescription Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Dog Prescription Drugs Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Dog Prescription Drugs Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Dog Prescription Drugs Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Dog Prescription Drugs Manufacturers Covered in This Study
Table 5. Global Dog Prescription Drugs Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Dog Prescription Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Dog Prescription Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Dog Prescription Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Dog Prescription Drugs Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Dog Prescription Drugs Sales Sites and Area Served
Table 11. Manufacturers Dog Prescription Drugs Product Types
Table 12. Global Dog Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Dog Prescription Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dog Prescription Drugs as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Dog Prescription Drugs Players
Table 16. Global Dog Prescription Drugs Sales (K Units) by Region (2015-2020)
Table 17. Global Dog Prescription Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Dog Prescription Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Dog Prescription Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 21. North America Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 25. Europe Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Dog Prescription Drugs Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Dog Prescription Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Dog Prescription Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Dog Prescription Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 33. Latin America Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Dog Prescription Drugs Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Dog Prescription Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Dog Prescription Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Dog Prescription Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Dog Prescription Drugs Sales (K Units) by Type (2015-2020)
Table 41. Global Dog Prescription Drugs Sales Share by Type (2015-2020)
Table 42. Global Dog Prescription Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Dog Prescription Drugs Revenue Share by Type (2015-2020)
Table 44. Global Dog Prescription Drugs Price (USD/Unit) by Type (2015-2020)
Table 45. Global Dog Prescription Drugs Sales (K Units) by Application (2015-2020)
Table 46. Global Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Dog Prescription Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Elanco Animal Health Dog Prescription Drugs Corporation Information
Table 49. Elanco Animal Health Description and Business Overview
Table 50. Elanco Animal Health Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. Elanco Animal Health Main Product
Table 52. Elanco Animal Health Recent Development
Table 53. Ceva Sante Animale Dog Prescription Drugs Corporation Information
Table 54. Ceva Sante Animale Corporation Information
Table 55. Ceva Sante Animale Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Ceva Sante Animale Main Product
Table 57. Ceva Sante Animale Recent Development
Table 58. MSD Animal Health Dog Prescription Drugs Corporation Information
Table 59. MSD Animal Health Corporation Information
Table 60. MSD Animal Health Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. MSD Animal Health Main Product
Table 62. MSD Animal Health Recent Development
Table 63. Zoetis Dog Prescription Drugs Corporation Information
Table 64. Zoetis Corporation Information
Table 65. Zoetis Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Zoetis Main Product
Table 67. Zoetis Recent Development
Table 68. Virbac Dog Prescription Drugs Corporation Information
Table 69. Virbac Corporation Information
Table 70. Virbac Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. Virbac Main Product
Table 72. Virbac Recent Development
Table 73. Dechra Dog Prescription Drugs Corporation Information
Table 74. Dechra Corporation Information
Table 75. Dechra Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Dechra Main Product
Table 77. Dechra Recent Development
Table 78. Vetoquinol Dog Prescription Drugs Corporation Information
Table 79. Vetoquinol Corporation Information
Table 80. Vetoquinol Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 81. Vetoquinol Main Product
Table 82. Vetoquinol Recent Development
Table 83. Animalcare Group Dog Prescription Drugs Corporation Information
Table 84. Animalcare Group Corporation Information
Table 85. Animalcare Group Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 86. Animalcare Group Main Product
Table 87. Animalcare Group Recent Development
Table 88. Ourofino Saude Animal Dog Prescription Drugs Corporation Information
Table 89. Ourofino Saude Animal Corporation Information
Table 90. Ourofino Saude Animal Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 91. Ourofino Saude Animal Main Product
Table 92. Ourofino Saude Animal Recent Development
Table 93. Boehringer Ingelheim Dog Prescription Drugs Corporation Information
Table 94. Boehringer Ingelheim Corporation Information
Table 95. Boehringer Ingelheim Dog Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 96. Boehringer Ingelheim Main Product
Table 97. Boehringer Ingelheim Recent Development
Table 98. Sales Base and Market Concentration Rate of Raw Material
Table 99. Key Suppliers of Raw Materials
Table 100. Dog Prescription Drugs Distributors List
Table 101. Dog Prescription Drugs Customers List
Table 102. Market Key Trends
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Global Dog Prescription Drugs Sales (K Units) Forecast by Type (2021-2026)
Table 106. Global Dog Prescription Drugs Sales Market Share Forecast by Type (2021-2026)
Table 107. Global Dog Prescription Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 108. Global Dog Prescription Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 109. Global Dog Prescription Drugs Sales (K Units) Forecast by Application (2021-2026)
Table 110. Global Dog Prescription Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 111. Global Dog Prescription Drugs Sales (K Units) Forecast by Region (2021-2026)
Table 112. Global Dog Prescription Drugs Sales Market Share Forecast by Region (2021-2026)
Table 113. Global Dog Prescription Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 114. Global Dog Prescription Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Dog Prescription Drugs
Figure 2. Global Dog Prescription Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Oral Type Product Picture
Figure 4. Smear Type Product Picture
Figure 5. Injection Type Product Picture
Figure 6. Spray Type Product Picture
Figure 7. Global Dog Prescription Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 8. Hospital
Figure 9. Clinic
Figure 10. Others
Figure 11. Global Dog Prescription Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Dog Prescription Drugs Sales Capacity (K Units) (2015-2026)
Figure 13. Global Dog Prescription Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Dog Prescription Drugs Sales Share by Manufacturers in 2020
Figure 15. Global Dog Prescription Drugs Revenue Share by Manufacturers in 2019
Figure 16. The Global 5 and 10 Largest Players: Market Share by Dog Prescription Drugs Revenue in 2019
Figure 17. Dog Prescription Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 18. Global Dog Prescription Drugs Sales Market Share by Region (2015-2020)
Figure 19. Global Dog Prescription Drugs Sales Market Share by Region in 2019
Figure 20. Global Dog Prescription Drugs Revenue Market Share by Region (2015-2020)
Figure 21. Global Dog Prescription Drugs Revenue Market Share by Region in 2019
Figure 22. North America Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 23. North America Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 24. U.S. Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 25. U.S. Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Canada Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 28. Europe Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 29. Europe Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 30. Germany Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. Germany Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. France Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. France Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. U.K. Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. U.K. Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Italy Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. Italy Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Russia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Russia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Asia Pacific Dog Prescription Drugs Sales Market Share by Region in 2019
Figure 41. Asia Pacific Dog Prescription Drugs Revenue Market Share by Region in 2019
Figure 42. China Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. China Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Japan Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Japan Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. South Korea Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. South Korea Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. India Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. India Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Australia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Australia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Taiwan Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. Taiwan Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Indonesia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 55. Indonesia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Thailand Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 57. Thailand Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Malaysia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. Malaysia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Philippines Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Philippines Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Vietnam Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. Vietnam Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Latin America Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 65. Latin America Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 66. Mexico Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Mexico Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Brazil Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Brazil Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Argentina Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Middle East and Africa Dog Prescription Drugs Sales Market Share by Country in 2019
Figure 73. Middle East and Africa Dog Prescription Drugs Revenue Market Share by Country in 2019
Figure 74. Turkey Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Turkey Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Saudi Arabia Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Saudi Arabia Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. U.A.E Dog Prescription Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. U.A.E Dog Prescription Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Sales Market Share of Dog Prescription Drugs by Type (2015-2020)
Figure 81. Sales Market Share of Dog Prescription Drugs by Type in 2019
Figure 82. Revenue Share of Dog Prescription Drugs by Type (2015-2020)
Figure 83. Revenue Market Share of Dog Prescription Drugs by Type in 2019
Figure 84. Global Dog Prescription Drugs Sales Growth by Type (2015-2020) (K Units)
Figure 85. Global Dog Prescription Drugs Sales Market Share by Application (2015-2020)
Figure 86. Global Dog Prescription Drugs Sales Market Share by Application in 2019
Figure 87. Global Revenue Share of Dog Prescription Drugs by Application (2015-2020)
Figure 88. Global Revenue Share of Dog Prescription Drugs by Application in 2020
Figure 89. Elanco Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Ceva Sante Animale Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. MSD Animal Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Zoetis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Virbac Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Dechra Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. Vetoquinol Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Animalcare Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Ourofino Saude Animal Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. Price Trend of Key Raw Materials
Figure 100. Manufacturing Cost Structure of Dog Prescription Drugs
Figure 101. Manufacturing Process Analysis of Dog Prescription Drugs
Figure 102. Dog Prescription Drugs Industrial Chain Analysis
Figure 103. Channels of Distribution
Figure 104. Distributors Profiles
Figure 105. Porter's Five Forces Analysis
Figure 106. North America Dog Prescription Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 107. North America Dog Prescription Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 108. Europe Dog Prescription Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 109. Europe Dog Prescription Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 110. Latin America Dog Prescription Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 111. Latin America Dog Prescription Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 112. Middle East and Africa Dog Prescription Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 113. Middle East and Africa Dog Prescription Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Asia Pacific Dog Prescription Drugs Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 115. Asia Pacific Dog Prescription Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Bottom-up and Top-down Approaches for This Report
Figure 117. Data Triangulation
Figure 118. Key Executives Interviewed
  • Global Knee Replacement Implants Market Growth 2020-2025
    Published: 25-Nov-2020        Price: US 3660 Onwards        Pages: 167
    According to this study, over the next five years the Knee Replacement Implants market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Knee Replacement Implants business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Knee Replacement Impl......
  • Global Medical Nutrition Market Growth (Status and Outlook) 2020-2025
    Published: 25-Nov-2020        Price: US 3660 Onwards        Pages: 117
    According to this study, over the next five years the Medical Nutrition market will register a 4.6%% CAGR in terms of revenue, the global market size will reach $ 39060 million by 2025, from $ 32650 million in 2019. In particular, this report presents the global revenue market share of key companies in Medical Nutrition business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Medical Nutrition market by product type,......
  • Global Cardiac Biomarker Market Growth 2020-2025
    Published: 25-Nov-2020        Price: US 3660 Onwards        Pages: 137
    According to this study, over the next five years the Cardiac Biomarker market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cardiac Biomarker business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Cardiac Biomarker market by product t......
  • Global Peony Root-Bark Extract Market Growth 2020-2025
    Published: 24-Nov-2020        Price: US 3660 Onwards        Pages: 159
    According to this study, over the next five years the Peony Root-Bark Extract market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Peony Root-Bark Extract business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Peony Root-Bark Extract m......
  • Global Pigskin Gelatin Market Growth 2020-2025
    Published: 24-Nov-2020        Price: US 3660 Onwards        Pages: 167
    According to this study, over the next five years the Pigskin Gelatin market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Pigskin Gelatin business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Pigskin Gelatin market by product type, a......
  • Global Fluff Sponges Market Growth 2020-2025
    Published: 24-Nov-2020        Price: US 3660 Onwards        Pages: 158
    According to this study, over the next five years the Fluff Sponges market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Fluff Sponges business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of Fluff Sponges market by product type, applica......
  • Global Sterile X-Ray Detectable Lap Sponges Market Growth 2020-2025
    Published: 24-Nov-2020        Price: US 3660 Onwards        Pages: 166
    According to this study, over the next five years the Sterile X-Ray Detectable Lap Sponges market will register a xx%% CAGR in terms of revenue, the global market size will reach $ xx million by 2025, from $ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Sterile X-Ray Detectable Lap Sponges business, shared in Chapter 3. This report presents a comprehensive overview, market shares, and growth opportunities of......
  • Muscarinic Acetylcholine Receptor M1 Antagonists - Pipeline Insight, 2020
    Published: 24-Nov-2020        Price: US 2000 Onwards        Pages: 70
    DelveInsight's, "Muscarinic Acetylcholine Receptor M1 Antagonists- Pipeline Insight, 2020," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Muscarinic Acetylcholine Receptor M1 Antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products i......
  • PARP Inhibitors - Pipeline Insight, 2020
    Published: 24-Nov-2020        Price: US 2500 Onwards        Pages: 80
    DelveInsight's, "PARP Inhibitors- Pipeline Insight, 2020," report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in PARP Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered - Global cov......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs